Inhibition of cysteine proteases by a natural biflavone: behavioral evaluation of fukugetin as papain and cruzain inhibitor

References

• Campetella O, Henriksson J, Aslund L, Frasch AC, Pettersson U, Cazzulo JJ. The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is encoded by multiple polymorphic tandemly organized genes located on different chromosomes. Mol Biochem Parasitol 1992;50:225–234.
   PubMed Web of Science ®Google Scholar
• Lima AP, Tessier DC, Thomas DY, Scharfstein J, Storer AC, Vernet T. Identification of new cysteine protease gene isoforms in Trypanosoma cruzi. Mol Biochem Parasitol 1994;67:333–338.
   PubMed Web of Science ®Google Scholar
• Caffrey CR, Hansell E, Lucas KD, Brinen LS, Alvarez Hernandez A, Cheng J et al. Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense. Mol Biochem Parasitol 2001;118:61–73.
   PubMed Web of Science ®Google Scholar
• Eakin AE, Mills AA, Harth G, McKerrow JH, Craik CS. The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi. J Biol Chem 1992;267:7411–7420.
   PubMed Web of Science ®Google Scholar
• Nkemgu NJ, Grande R, Hansell E, McKerrow JH, Caffrey CR, Steverding D. Improved trypanocidal activities of cathepsin L inhibitors. Int J Antimicrob Agents 2003;22:155–159.
   PubMed Web of Science ®Google Scholar
• Steverding D, Caffrey CR, Sajid M. Cysteine proteinase inhibitors as therapy for parasitic diseases: advances in inhibitor design. Mini Rev Med Chem 2006;6:1025–1032.
   PubMed Web of Science ®Google Scholar
• Engel JC, Doyle PS, McKerrow JH. [Trypanocidal effect of cysteine protease inhibitors in vitro and in vivo in experimental Chagas disease]. Medicina (B Aires) 1999;59 Suppl 2:171–175.
   PubMed Web of Science ®Google Scholar
• Vicik R, Hoerr V, Glaser M, Schultheis M, Hansell E, McKerrow JH et al. Aziridine-2,3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents. Bioorg Med Chem Lett 2006;16:2753–2757.
   PubMed Web of Science ®Google Scholar
• Engel JC, Doyle PS, Hsieh I, McKerrow JH. Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection. J Exp Med 1998;188:725–734.
   PubMed Web of Science ®Google Scholar
• Engel JC, Doyle PS, Palmer J, Hsieh I, Bainton DF, McKerrow JH. Cysteine protease inhibitors alter Golgi complex ultrastructure and function in Trypanosoma cruzi. J Cell Sci 1998;111 (Pt 5):597–606.
   PubMed Web of Science ®Google Scholar
• McKerrow JH, Doyle PS, Engel JC, Podust LM, Robertson SA, Ferreira R et al. Two approaches to discovering and developing new drugs for Chagas disease. Mem Inst Oswaldo Cruz 2009;104 Suppl 1:263–269.
   PubMed Web of Science ®Google Scholar
• Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000;52:673–751.
   PubMed Web of Science ®Google Scholar
• Zeng GZ, Pan XL, Tan NH, Xiong J, Zhang YM. Natural biflavones as novel inhibitors of cathepsin B and K. Eur J Med Chem 2006;41:1247–1252.
   PubMed Web of Science ®Google Scholar
• Eakin AE, Mills AA, Harth G, McKerrow JH, Craik CS. The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi. J Biol Chem. 1992, 267: 7411–7420.
   PubMed Web of Science ®Google Scholar
• Barrett AJ, Kirshke H. Cathepsin B, cathepsin H, cathepsin L. Methods Enzymol. 1991, 80: 535–561.
   Google Scholar
• Melo RL, Alves LC, Del Nery E, Juliano L, Juliano MA. Synthesis and hydrolysis by cysteine and serine proteases of short internally quenched fluorogenic peptides. Anal Biochem 2001;293:71–77.
   PubMed Web of Science ®Google Scholar
• Derogis PB, Martins FT, de Souza TC, de C Moreira ME, Souza Filho JD, Doriguetto AC et al. Complete assignment of the 1H and 13C NMR spectra of garciniaphenone and keto-enol equilibrium statements for prenylated benzophenones. Magn Reson Chem 2008;46:278–282.
   PubMed Web of Science ®Google Scholar
• Konoshima M, Ikeshiro Y, Nishinaga A, et al. The constitution of flavonoids from hook. Tetr Lett 1969;10:121–124.
   Google Scholar
• Botta B, Mac-Quhae MM, Monache GM, Monache FM, De Mello JF. Chemical Investigation of the Genus Rheedia, V. Biflavonoids and Xanthochymol. J Nat Prod. 1984, 47:1053.
   Web of Science ®Google Scholar
• Li X, Joshi AS, Tan B, Elsohly HN, Walker LA, Zjawiony JK, Ferreira D. Absolute configuration, conformation, and chiral properties of flavanone-(3→8″)-flavone biflavonoids from Rheedia acuminate. Tetrahedron. 2002, 58:8709–8717.
   Web of Science ®Google Scholar
• Enraf-Nonius COLLECT.;Nonius BV. Delft, The Netherlands, 1997–2000.
   Google Scholar
• Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 1997, 276: 307–326.
   PubMed Web of Science ®Google Scholar
• Sheldrick GM. SHELXS-97 Program for Crystal Structure Resolution. Germany:University of Göttingen, 1997.
   Google Scholar
• Sheldrick GM. SHELXL-97 Program for Crystal Structure Refinement. Germany: University of Göttingen, 1997.
   Google Scholar
• Farrugia LJ. WinGX suite for small-molecule single-crystal crystallography. J Appl Crystallogr. 1999, 32:837.
   Web of Science ®Google Scholar
• Farrugia LJ. ORTEP-3 for Windows - a version of ORTEP-III with a Graphical User Interface (GUI). J Appl Crystallogr 1997, 30:565.
   Web of Science ®Google Scholar
• Bruno IJ, Cole JC, Edgington PR, Kessler M, Macrae CF, McCabe P et al. New software for searching the Cambridge Structural Database and visualizing crystal structures. Acta Crystallogr, B 2002;58:389–397.
   PubMed Web of Science ®Google Scholar
• Morrison JF, Walsh CT. The behavior and significance of slow-binding enzyme inhibitors. Adv Enzymol Relat Areas Mol Biol 1988;61:201–301.
   PubMedGoogle Scholar
• Baici A, Schenker P, Wächter M, Rüedi P. 3-Fluoro-2,4-dioxa-3-phosphadecalins as inhibitors of acetylcholinesterase. A reappraisal of kinetic mechanisms and diagnostic methods. Chem Biodivers 2009;6:261–282.
   PubMed Web of Science ®Google Scholar
• Lineweaver H, Burk D. The Determination of Enzyme Dissociation Constants. J Am Chem Soc 1934 56:658–666.
   Web of Science ®Google Scholar
• Michaelis L, Menten ML. Die Kinetik der Inwertin Wirkung. Biochem Z 1913, 49:333–339.
   Google Scholar
• Segel IH. Enzyme kinetics behavior and analysis of rapid equilibrium and steady-state enzyme systems, pp. 470–473, New York:John Wiley & Sons.
   Google Scholar
• SiteMap, version 2.3, Schrödinger, LLC, New York, NY, 2009.
   Google Scholar
• Hof P, Mayr I, Huber R, Korzus E, Potempa J, Travis J et al. The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities. EMBO J 1996;15:5481–5491.
   PubMed Web of Science ®Google Scholar
• Brinen LS, Hansell E, Cheng J, Roush WR, McKerrow JH, Fletterick RJ. A target within the target: probing cruzain’s P1′ site to define structural determinants for the Chagas’ disease protease. Structure 2000;8:831–840.
   PubMed Web of Science ®Google Scholar
• Schrödinger Suite 2009 Protein Preparation Wizard; Epik version 2.0, Schrödinger, LLC, New York, NY, 2009; Impact version 5.5, Schrödinger, LLC, New York, NY, 2009; Prime version 2.1, Schrödinger, LLC, New York, NY, 2009.
   Google Scholar
• Schrödinger Suite 2009 QM-Polarized Ligand Docking protocol; Glide version 5.5, Schrödinger, LLC, New York, NY, 2009; Jaguar version 7.6, Schrödinger, LLC, New York, NY, 2009; QSite version 5.5, Schrödinger, LLC, New York, NY, 2009.
   Google Scholar
• Alves CR, Corte-Real S, Bourguignon SC, Chaves CS, Saraiva EM. Leishmania amazonensis: early proteinase activities during promastigote-amastigote differentiation in vitro. Exp Parasitol 2005;109:38–48.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248–254.
   PubMed Web of Science ®Google Scholar
• McGrath ME, Eakin AE, Engel JC, McKerrow JH, Craik CS, Fletterick RJ. The crystal structure of cruzain: a therapeutic target for Chagas’ disease. J Mol Biol 1995;247:251–259.
   PubMed Web of Science ®Google Scholar
• Gillmor SA, Craik CS, Fletterick RJ. Structural determinants of specificity in the cysteine protease cruzain. Protein Sci 1997;6:1603–1611.
   PubMed Web of Science ®Google Scholar
• Burley SK, Petsko GA. Aromatic-aromatic interaction: a mechanism of protein structure stabilization. Science 1985;229:23–28.
   PubMed Web of Science ®Google Scholar
• Durrant JD, Keranen H, Wilson BA, McCammon JA. Computational identification of uncharacterized cruzain binding sites. PLoS Negl Trop Dis 2010, 4:676.
   Web of Science ®Google Scholar
• Gilles AM, Keil B. Evidence for an active-center cysteine in the SH-proteinase α-clostripain through use of N-tosyl-L-lysine chloromethyl ketone. FEBS Lett 1984;173:58–62.
   PubMed Web of Science ®Google Scholar
• Brak K, Doyle PS, McKerrow JH, Ellman JA. Identification of a new class of nonpeptidic inhibitors of cruzain. J Am Chem Soc 2008;130:6404–6410.
   PubMed Web of Science ®Google Scholar
• Brak K, Kerr ID, Barrett KT, Fuchi N, Debnath M, Ang K et al. Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy. J Med Chem 2010;53:1763–1773.
   PubMed Web of Science ®Google Scholar
• Abe F, Nagafuji S, Okabe H, Higo H, Akahane H. Trypanocidal constituents in plants 2.xanthones from the stem bark of Garcinia subelliptica. Biol Pharm Bull 2003;26:1730–1733.
   PubMed Web of Science ®Google Scholar
• Pan X, Tan N, Zeng G, Zhang Y, Jia R. Amentoflavone and its derivatives as novel natural inhibitors of human Cathepsin B. Bioorg Med Chem 2005;13:5819–5825.
   PubMed Web of Science ®Google Scholar